You are here:
Explore documents related to applying for all types of Gavi support including FAQs, instructions and application forms
09 June 2017
Guidance note for PEF TCA process
Guidance to country stakeholders, Gavi partners and the Gavi Secretariat on the process related to Targeted Country Assistance (TCA).
06 April 2017
Guidelines on financial audits for Gavi cash-based support
Guidelines on financial audits for Gavi cash-based support clarify Gavi’s audit requirements and assist the implementing entity in ensuring that the audit process is conducted in an efficient manner.
29 March 2017
Guidelines on reporting and renewal of Gavi support
The guidelines on reporting and renewal of Gavi support are intended to provide to countries an overview of the reporting requirements for Gavi support, as well as a description of the annual performance assessment and renewal process.
28 March 2017
Joint Appraisal analysis guidance
The Joint Appraisal analysis guidance outlines the suggested minimum set of data and analyses to be made available to inform Joint Appraisal discussions, and builds on country examples from previous Joint Appraisals found to be particularly effective. For each area of analysis, illustrative examples of how some of the suggested analyses may be presented/compiled are included.
24 March 2017
PCV 4-dose vials FAQs
Frequently asked questions on the 4-dose vials of pneumococcal conjugate vaccines. [French] [Spanish] [Russian]
06 March 2017
Gavi guidelines to support countries' HR capacity
Human resources capacity in Gavi-eligible countries can be a major bottleneck for coverage and equity of immunisation. To complement HR capacity, countries can request Gavi support for funding staff at the management and service delivery levels.
07 February 2017
Product Switch Budget Template
Budget template for product and/or presentation switches for Gavi-supported vaccines. This document is intended to be used by countries applying for a Gavi product switch grant. [French]
20 December 2016
Guidance on financial reporting
Gavi Financial Management & Audit Requirements outline the principles and requirements for recipients of Gavi support applicable as of 1st January 2016. Accompanying these guidelines are a set of templates and examples for use.
14 December 2016
HPV vaccine application guidelines package
HPV vaccine application guidelines package.
28 November 2016
PCV Application guidelines transitioning countries
Guidelines for applications for access to pneumococcal vaccines for countries that are in accelerated transition or have transitioned out of Gavi support.
Rotavirus vaccine application guidelines package
Rotavirus vaccine application guidelines package.
Pneumococcal vaccine application guidelines package
Pneumococcal vaccine application guidelines package.
Yellow fever vaccine application guidelines package
Yellow fever vaccine application guidelines package.
Meningitis A conjugate vaccine application guidelines package
Meningitis A conjugate vaccine application guidelines package.
Measles and rubella vaccine application guidelines package
Measles and rubella vaccine application guidelines package.
Japanese encephalitis vaccine application guidelines package
Japanese encephalitis vaccine application guidelines package.
IRC Review Criteria
The criteria used by the Independent Review Committee (IRC) to assess applications.
Cold Chain Equipment Optimisation Platform application guidelines package
Application guidelines package for Cold Chain Equipment Optimisation Platform support.
11 November 2016
National coordination forums - Guidance on coordination forums
Guidance for national-level coordination forums (e.g. ICCs, HSCCs or equivalent bodies), including Gavi’s requirements and recommendations on their mandate, membership and governance best practices.
05 October 2016
Guidance on developing demand generation plans
Gavi guidance on how to develop and implement demand promotion interventions.
20 October 2015
Performance Framework Overview
An overview of the definition, content, use and introduction of the performance framework.
09 September 2015
Guidance on evaluation of HSS grants
Information on independent evaluations of Gavi HSS grants.
Guidance on investments with high impact potential
Information on bottlenecks and associated activities that have been determined to have a high potential impact on immunisation outcomes.
HPV resources
Links to useful resources for more information on the HPV vaccine.
Guidance on grant modification for fragile countries
Information on when countries in emergency situations or with exceptional challenges may be eligible for additional flexibilities under the Fragility and Immunisation Policy.
Guidance for developing vaccine introduction plans
Guidance on completing new vaccine introduction operational plans and a Plan of Action.
2015-2016 Gavi HSS Country Ceilings
Gavi’s total funding envelope for each country.
Co-financing default
Information on what happens when a country does not fulfil its co-financing requirement on time.
21 August 2015
FAQ - Civil Society Access to GAVI Pricing for Vaccines
1 Civil society access to GAVI pricing for vaccines Frequently asked questions September 2013 1. Does GAVI support the delivery of immunisation services by civil society organisations? GAVI recognises the key role that civil society organisations (CSOs) play in the national immunisation programmes of many countries. 2.
03 August 2015
Gavi's grant application, monitoring and review redesign
Overview of how Gavi is enhancing its routine grant monitoring and reporting.
30 June 2015
FAQ - Grant management change process
The Gavi Alliance grant management change process Frequently asked questions May 2015 Overall change process 1. How was it decided that grant management changes were needed? Over recent years, through a series of consultation sessions, the Gavi Alliance Board, Programme and Policy Committee (PPC), partners, countries,
22 December 2014
Gavi and Ebola - FAQ
Gavi and Ebola - Frequently asked questions.
18 August 2014
GAVI HSS Grant Categorisation 2014
This table is intended to provide ideas of HSS activities to applicants and to allow GAVI to analyse its HSS support by type of grants.
01 July 2014
GNI per capita 2013
Gross national income per capita 2013.
10 March 2014
Delivering results in HSS information sheet
Information sheet about measuring results for health system performance and improving data quality.
Human Papillomavirus vaccines information sheet
Human Papillomavirus vaccines information sheet.
Guidance on GAVI HSS approach and application process
Health system strengthening approach information sheet.
Performance Based Funding information sheet
Information sheet about GAVI’s HSS Performance Based Funding.
14 June 2013
Frequently asked questions about Gavi's co-financing
Frequently asked questions about co-financing.
26 March 2013
Request form for emergency response
As outlined in the GAVI policy on fragility and immunisation, GAVI will provide one-off flexibilities in order to help protect immunisation systems and existing GAVI support in countries experiencing time-limited emergencies. This form is developed to assist countries in such emergency circumstances wanting to apply for these flexibilities.
22 March 2013
CSO Implementation and Results Framework
The GAVI Board has decided that HSS will be the single window for GAVI cash grants. GAVI support for CSOs will be part of a country Health Systems Strengthening (HSS) proposal to improve immunisation outcomes. The document presents why and how GAVI works with and supports CSOs in programme implementation.
12 September 2012
HSS Policy Timeline
Health System Strengthening (HSS) Policies and Major Decisions at GAVI Timeline and Overview.
Gavi documents
modal window here